Annexon Inc (ANNX)

Currency in USD
5.880
-0.180(-2.97%)
Closed·
5.8800.000(0.00%)
·
ANNX is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
5.8116.110
52 wk Range
1.6007.180
Key Statistics
Prev. Close
6.06
Open
6.06
Day's Range
5.811-6.11
52 wk Range
1.6-7.18
Volume
1.39M
Average Volume (3m)
2.56M
1-Year Change
217.2775%
Book Value / Share
1.42
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ANNX Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
13.714
Upside
+133.24%
Members' Sentiments
Bearish
Bullish
ProTips
Quickly burning through cash

Annexon Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops medicines for treating inflammatory-related diseases. The company provides Tanruprubart, an investigational full-length monoclonal antibody, which is in Phase 3 clinical trial for the treatment of patients with guillain-barré syndrome; completed Phase II clinical trial for treating Huntington’s disease; and in Phase 2a clinical trial for the treatment of amyotrophic lateral sclerosis. It is also developing ANX007, an antigen-binding fragment (Fab) that is in Phase 3 program for the treatment of patients with geographic atrophy; and ANX1502, a novel oral small molecule inhibitor, which is in Phase 1 clinical trials for autoimmune indications. In addition, it develops ANX009, a C1q-blocking Fab that is in Phase I clinical trial for treating patients with lupus nephritis. The company was incorporated in 2011 and is headquartered in Brisbane, California.

Compare ANNX to Peers and Sector

Metrics to compare
ANNX
Peers
Sector
Relationship
P/E Ratio
−4.6x−7.1x−0.5x
PEG Ratio
0.14−0.120.00
Price/Book
4.5x6.5x2.6x
Price / LTM Sales
-198.3x3.2x
Upside (Analyst Target)
87.1%252.5%47.4%
Fair Value Upside
Unlock−16.4%7.7%Unlock

Analyst Ratings

9 Buy
0 Hold
0 Sell
Ratings:
9 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 13.714
(+133.24% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Jefferies
Buy10.00+70.07%-MaintainMar 31, 2026
H.C. Wainwright
Buy14.00+138.10%-MaintainMar 20, 2026
Cantor Fitzgerald
Buy---MaintainMar 19, 2026
Cantor Fitzgerald
Buy---MaintainJan 14, 2026
Chardan Capital Markets
Buy16.00+172.11%-New CoverageDec 23, 2025

Earnings

Latest Release
Mar 31, 2026
EPS / Forecast
-0.28 / -0.32
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

ANNX Income Statement

People Also Watch

3.98
ZNTL
+2.31%
13.22
CGEM
+2.08%
1.54
PEPG
-3.14%
17.05
BIOA
-1.10%

FAQ

What Is the Annexon (ANNX) Stock Price Today?

The Annexon stock price today is 5.880 USD.

What Stock Exchange Does Annexon Trade On?

Annexon is listed and trades on the Nasdaq Stock Exchange.

What Is the Stock Symbol for Annexon?

The stock symbol for Annexon is "ANNX."

What Is the Annexon Market Cap?

As of today, Annexon market cap is 955.540M USD.

What Is Annexon's Earnings Per Share (TTM)?

The Annexon EPS (TTM) is -1.345.

When Is the Next Annexon Earnings Date?

Annexon will release its next earnings report on May 18, 2026.

From a Technical Analysis Perspective, Is ANNX a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.

How Many Times Has Annexon Stock Split?

Annexon has split 0 times.

How Many Employees Does Annexon Have?

Annexon has 96 employees.

What is the current trading status of Annexon (ANNX)?

As of Apr 25, 2026, Annexon (ANNX) is trading at a price of 5.880 USD, with a previous close of 6.060 USD. The stock has fluctuated within a day range of 5.811 USD to 6.110 USD, while its 52-week range spans from 1.600 USD to 7.180 USD.

What Is Annexon (ANNX) Price Target According to Analysts?

The average 12-month price target for Annexon is 13.714 USD, with a high estimate of 27 USD and a low estimate of 8 USD. 9 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +133.24% Upside potential.

What Is the ANNX Premarket Price?

ANNX's last pre-market stock price is 6.080 USD. The pre-market share volume is 1,080.000, and the stock has decreased by 0.020, or 0.330%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.